ED
NBRV

Exane Derivatives’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Exane Derivatives’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-540
Closed -$71.9K – 859
2020
Q3 		$71.9K Buy
540
+100
+23% +$13.3K 0.02% 330
2020
Q2 		$74.3K Buy
440
+112
+34% +$18.9K 0.02% 306
2020
Q1 		$47.2K Buy
+328
New +$47.2K 0.01% 336